Intravesical Platelet-Rich Plasma Injection for Refractory Interstitial Cystitis/Painful Bladder Syndrome: A Systematic Review and Meta-analysis
International Urogynecology Journal · 2026-06 · 37 (6) · 1515-1522
DOI: 10.1007/s00192-026-06515-9 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift International Urogynecology Journal, online erschienen am 06.04.2026. Verfasst von Gabriel Chahade Sibanto Simões und 4 weiteren Autor:innen. Beteiligte Einrichtung: State University of Campinas (UNICAMP), Campinas, SP, Brazil. gabrielcssimoes@gmail.com. Hauptthemen laut MEDLINE: Cystitis, Interstitial, Platelet-Rich Plasma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidade Estadual De Campinas.
Abstract (Originalsprache)
Introduction and Hypothesis Intravesical injection of platelet-rich plasma (PRP) has emerged as a novel therapeutic approach for patients with interstitial cystitis/ bladder pain syndrome (IC/BPS). This systematic review and meta-analysis aim to evaluate the efficacy of PRP in alleviating pain and other related symptoms and outcomes in women.
Methods
This systematic review and meta-analysis followed PRISMA guidelines and the PICO framework. A comprehensive search was conducted in multiple databases. Risk of bias was assessed using the Cochrane Review Manager (RevMan), and quality of evidence was evaluated using the Modified Oxford Centre for Evidence-Based Medicine tool. All included studies were quasi-experimental, uncontrolled, and non-randomized, resulting in a low overall level of evidence . A pre–post meta-analysis was performed assessing outcomes such as Global Response Assessment (GRA), pain (VAS), symptom scores (ICSI, ICPI, OSS), urinary frequency, nocturia, and urodynamic parameters. Standardized mean differences were calculated using a random-effects model, and heterogeneity was assessed using Cochran’s Q test and the I 2 statistic.
Results
The meta-analysis revealed a potential treatment effect, with a mean success rate (GRA ≥ 2) of 48%. Given that all the results derive from uncontrolled and non-randomized studies, they should therefore be interpreted with caution. Statistically significant improvements were observed in pain scores, urinary frequency, nocturia, and bladder function, including increases in Qmax and voided volume.
Conclusions
Intravesical PRP injection may represent a promising therapeutic option for refractory IC/BPS, showing trends toward improvement in pain, nocturia, frequency, and bladder capacity. However, as current evidence is derived exclusively from uncontrolled and non-randomized studies, its efficacy remains uncertain and the findings should be interpreted with caution. Nonetheless, higher-quality randomized controlled trials are required to confirm its efficacy and better define its role in clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State University of Campinas (UNICAMP), Campinas, SP, Brazil. gabrielcssimoes@gmail.com.
- State University of Campinas (UNICAMP), Campinas, SP, Brazil.
Förderung
- Universidade Estadual De Campinas
Zitieren
APA
Simões, G. C. S., de Oliveira, C., Gon, L. M., Riccetto, C. L. Z., & Simões, G. C. S. (2026). Intravesical Platelet-Rich Plasma Injection for Refractory Interstitial Cystitis/Painful Bladder Syndrome: A Systematic Review and Meta-analysis. International Urogynecology Journal, 37(6), 1515-1522. https://doi.org/10.1007/s00192-026-06515-9
Vancouver
Simões GCS, de Oliveira C, Gon LM, Riccetto CLZ, Simões GCS. Intravesical Platelet-Rich Plasma Injection for Refractory Interstitial Cystitis/Painful Bladder Syndrome: A Systematic Review and Meta-analysis. International Urogynecology Journal. 2026;37(6):1515-1522. doi:10.1007/s00192-026-06515-9
BibTeX
@article{Simes2026,
author = {Simões, Gabriel Chahade Sibanto and de Oliveira, Caio and Gon, Lucas Mira and Riccetto, Cássio Luís Zanettini and Simões, Gabriel Chahade Sibanto},
title = {Intravesical Platelet-Rich Plasma Injection for Refractory Interstitial Cystitis/Painful Bladder Syndrome: A Systematic Review and Meta-analysis},
journal = {International Urogynecology Journal},
year = {2026},
volume = {37},
number = {6},
pages = {1515--1522},
doi = {10.1007/s00192-026-06515-9}
}
EUVIMED